Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis

Chinese Medical Journal

Volumn 117, Issue 10, 2004, Pages 1530-1535

  Wu, Yun Fei ^a   Xu, Hui Mian ^a   Chen, Jun Qing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Bromodeoxyuridine; DNA; Lymphatic metastasis; Prognosis; Stomach neoplasms; Venous invasion

Indexed keywords

BROXURIDINE; DNA; MONOCLONAL ANTIBODY; PROPIDIUM IODIDE;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER SURVIVAL; CARCINOMA CELL; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION ANALYSIS; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MITOSIS; NONHUMAN; PLOIDY; PROGNOSIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH CARCINOMA; STUDENT T TEST;

ADULT; AGED; BROMODEOXYURIDINE; CELL CYCLE; CELL DIVISION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PLOIDIES; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 8844266849     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Baba H, Korenaga D, Kakeji Y, et al. DNA ploidy and clinical implications in gastric cancer. Surgery 2002;131: S63-S70.
2. Santoro E, Carboni M, Catarci M, et al. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer-a multivariate analysis. Hepatogastroenterology 1997;44:826-837.
3. Ranaldi R, Santinelli A, Fabris G, et al. A flow cytometric study of early gastric cancer. The detection of high proliferative activity adds important information to the prognosis. Pathol Res Pract 1996;192:1202-1205.
4. Chistyakova O, Zubrikhina GN. Flow cytometric analysis of DNA content in gastric and colorectal cancer. Anal Quant Cytol Histol 1998;20:52-58.
5. Kim JY, Cho HJ. DNA ploidy patterns in gastric adenocarcinoma. J Korean Med Sci 2000;15:159-166.
6. Abad M, Ciudad J, Rincon MR, et al. DNA aneuploidy by flow cytometry is an independent prognostic factor in gastric cancer. Anal Cell Pathol 1998;16:223-231.
7. Yonemura Y, Ooyama S, Sugiyama K, et al. Retrospective analysis of prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma. Cancer Res 1990;50: 509-514.
8. Wu YF, Chen JQ, He SG. The study of DNA content, cellular proliferative fraction and lymphatic nodes metastasis in gastric carcinoma. Chin J Oncol (Chin) 1997;19:62-64.
9. Yokota T, Kunii Y, Saito T, et al. Prognostic factors of gastric cancer tumors of less than 2 cm in diameter: rationale for limited surgery. Eur J Surg Oncol 2002;28:209-213.
10. Cascinu S, Graziano F, Catalano V, et al. Prognostic value of S-phase fraction in T3N0M0 gastric cancer. Anticancer Res 2000;20:3839-3842.
11. Santoro E, carboni H, Catorci H, et al. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer-a multivariate analysis. Hepatogastroenterology 1997;44:826-837.
12. Lee KH, Lee JS, Kim SW, et al. Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study. Br J Cancer 1999;79:1727-1735.
13. Abad M, Ciudad J, Rincon MR, et al. DNA aneuploidy by flow cytometry is an independent prognostic factor in gastric cancer. Anal cell pathol 1998;16:223-231.
14. Setala LP, Nordling S, Kosma VM, et al. Comparison of DNA and S-phase fraction with prognostic factors in gastric cancer. Anal Quant Cytol Histol 1997;19:524-532.
15. Schutte B, Reynders MM, Wigger T, et al. Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer 1987; 47:5494-5496.
16. Abe N, Watanabe T, Suzuki K, et al. Risk factors predictive of lymph node metastasis in depressed early gastric cancer. Am J Surg 2002;183:168-172.
17. Russo A, Bazan V, Migliavacca M, et al. DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: results of a 5-year Gruppo Oncologico dell' Italia Meridonale (GDIM) prospective study. Cancer 2001;92: 294-302.
18. Maehara Y, Kabashima A, Koga T, et al. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma. Surgery 2000; 128:408-416.
19. Ohyama S, Yonemura Y, Miyazaki I. Proliferative activity and malignancy in human gastric cancers. Cancer 1992;69: 314-321.
20. Setala L, Kosma V, Marin S, et al. Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer 1996;74: 766-772.
21. Maehara Y, Tomoda M, Hasuda S, et al. Prognostic value of P53 protein expression for patients with gastric cancer-a multivariate analysis. Br J Cancer 1999;79:1255-1261.
22. Yonemura Y, Sugiyama K, Fujimura T, et al. Correlation of DNA ploidy and proliferative activity in human gastric cancer. Cancer 1988;62:1492-1502.
23. Victorzon M, Roberts PJ, Haglund C, et al. Ki-67, ploidy and S-phase fraction as prognostic fractors in gastric cancer. Anticancer Res 1997;17:2923-2926.
24. Victorzon M, Roberts PJ, Haglund C, et al. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma. Oncology 1996;53: 182-191.
25. Russo A, Baszan V, Migliavacca M, et al. Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma. Clin cancer Res 2000;6:178-184.
26. Ohyama S, Yonemura Y, Miyazaki I. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of BrdUrd on human gastric cancer. Cancer 1990;65:116-121.
27. Kimura H, Yonemura Y. Flow cytometric analysis of nuclear DNA content in advanced gastric cancer and its relationship with prognosis. Cancer 1991;67:2588-2593.
28. Yonemura Y, Ooyama S, Sugiyama K, et al. Growth fractions in gastric carcinomas determined with monoclonal antibody Ki-67. Cancer 1990;65:1130-1134.
29. Volm M, Hahn EW, Mattern J. Five-year following-up study of independent clinical and flow cytometric prognostic factors ffor the survival of patients with non-small cell lung carcinoma. Cancer Res 1988;48:2923-2928.